Loading…
avatar for David Reddy

David Reddy

Medicines for Malaria Venture
CEO / PDG

Dr. David Reddy has been CEO of Medicines for Malaria Venture since January 2011. Under his leadership, this not-for-profit research foundation has brought forward four new antimalarial drugs and broadened its malaria-drug pipeline to include 7 novel drugs in clinical development. Prior to joining MMV, David was a Vice President in the Global Product Strategy unit at F. Hoffman-La Roche Ltd, Basel Switzerland, where he served as Pandemic Taskforce Leader. Prior to that he was the Global Franchise Leader for HIV/AIDS at Roche, where he oversaw the successful development and introduction of enfuvirtide, the first HIV fusion inhibitor. His resume includes over 20 years of Pharma experience, including successful leadership of drug development teams, licensing and alliance management, product and disease area management, market analytics and business planning. His roles also included interfacing with governments, NGOs, and patient advocacy groups around access to medicines for priority diseases.